Pancreatic Cancer Research

ResearcherMemorial Sloan Kettering Cancer CenterActive in the last 2 years

Kayvan R. Keshari

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5181-8035; OpenAlex author ID A5020635318. Sources: ClinicalTrials.gov.

Their work

Papers
3 (first author 1, last author 0)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2015: 1 trial · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 2 papers · 2022: none · 2023: none · 2024: 1 paper

Papers 3

  1. Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancer. Co-author DOI 10.1038/s41591-024-03075-7↗
  2. Deuterium Metabolic Imaging of Pancreatic Cancer. First author DOI 10.1002/nbm.4603↗
  3. Hyaluronic acid fuels pancreatic cancer cell growth. Co-author DOI 10.7554/elife.62645↗

Trials 1

  1. Characterization of Hyperpolarized Pyruvate MRI Reproducibility Principal investigator NCT02421380↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Guannan Zhang · 1 shared paper, 2021 · strength 0.28
  2. Christopher J. Halbrook · 1 shared paper, 2021 · strength 0.10
  3. Daniel M. Kremer · 1 shared paper, 2021 · strength 0.10
  4. Haoqiang Ying · 1 shared paper, 2021 · strength 0.10
  5. Peter Kim · 1 shared paper, 2021 · strength 0.10
  6. Megan D. Radyk · 1 shared paper, 2021 · strength 0.10
  7. Samuel Andrew Kerk · 1 shared paper, 2021 · strength 0.10
  8. Costas Andreas Lyssiotis · 1 shared paper, 2021 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.